Slug: the-complete-glp-1-medications-list-brands-dosages-and-uses
| Metric | Status |
|---|---|
| Category | Reviews |
| Primary Uses | Weight Loss, Type 2 Diabetes |
| Delivery Methods | Weekly Subcutaneous, Daily Oral |
| Market Status | Rapidly Expanding (New 2026 Approvals) |
| Verdict | Game-Changer |
Quick Summary: The GLP-1 landscape has evolved faster in the last two years than in the previous decade. With the recent 2026 FDA approval of Foundayo (the first food-independent oral GLP-1) and the re-branding of high-dose Oral Ozempic, consumers now have more choices: and more confusion: than ever. This guide breaks down the current glp 1 medication list to help you navigate your options.
Explore our full directory of GLP-1 Providers
The 2026 GLP-1 Landscape: What's Changed?
If you’ve been following the world of metabolic health, you know that the "Big Three" (Ozempic, Wegovy, and Mounjaro) dominated the conversation for years. However, as of April 2026, the market has shifted toward accessibility and oral formulations.
The biggest hurdles: refrigeration, needle phobia, and the strict "fasting" requirements of early oral meds like Rybelsus: are being cleared. The glp drugs list now includes options that fit seamlessly into a busy lifestyle without requiring you to wait 30 minutes for your morning coffee.
1. Semaglutide: The Foundation of the GLP-1 Market
Semaglutide remains the most researched and widely recognized molecule in the glp 1 drugs category. It is marketed under several brand names depending on its delivery method and intended use.
Injectable Semaglutide (Ozempic & Wegovy)
- Ozempic: Primarily FDA-approved for Type 2 Diabetes but frequently used off-label for weight management.
- Wegovy: FDA-approved specifically for chronic weight management.
- Dosage: Typically starts at 0.25 mg once weekly, titrating up to 2.0 mg (Ozempic) or 2.4 mg (Wegovy).
Oral Semaglutide (Rybelsus & Oral Ozempic)
- Rybelsus: The original oral version, available in 3 mg, 7 mg, and 14 mg tablets. Requires strict fasting.
- Oral Ozempic (New 2026): A higher-bioavailability tablet approved in February 2026. It comes in 1.5 mg, 4 mg, and 9 mg doses, offering potency closer to the injectable versions.
2. Tirzepatide: The Dual-Agonist Powerhouse
Tirzepatide is unique because it targets two receptors: GLP-1 and GIP (glucose-dependent insulinotropic polypeptide). This "dual-action" approach often results in greater weight loss outcomes compared to semaglutide alone.
- Mounjaro: Approved for Type 2 Diabetes.
- Zepbound: Approved specifically for weight loss.
- Dosage: Once-weekly injections starting at 2.5 mg and increasing in 2.5 mg increments up to a maximum of 15 mg.
3. Orforglipron (Brand Name: Foundayo)
The newest addition to the glp 1 medication list, Foundayo, received FDA approval on April 1, 2026. It represents a massive leap forward for oral weight loss treatments.
- Primary Benefit: It is a non-peptide molecule, meaning it isn't broken down by stomach acid as easily as semaglutide. You can take it any time of day, with or without food.
- Dosage: Once-daily tablet.
- Cost Advantage: Because it’s easier to manufacture than peptides, the self-pay price is often lower than injectable counterparts.
Comprehensive GLP-1 Medications List Comparison
| Brand Name | Molecule | Primary Use | Frequency | Delivery |
|---|---|---|---|---|
| Wegovy | Semaglutide | Weight Loss | Weekly | Injectable |
| Zepbound | Tirzepatide | Weight Loss | Weekly | Injectable |
| Foundayo | Orforglipron | Weight Loss | Daily | Oral Pill |
| Ozempic | Semaglutide | Diabetes | Weekly | Injectable |
| Mounjaro | Tirzepatide | Diabetes | Weekly | Injectable |
| Rybelsus | Semaglutide | Diabetes | Daily | Oral Pill |
| Saxenda | Liraglutide | Weight Loss | Daily | Injectable |
| Victoza | Liraglutide | Diabetes | Daily | Injectable |
4. Liraglutide: The Daily Injectable
While newer weekly medications have stolen the spotlight, Liraglutide remains a vital part of the glp drugs list for those who may not tolerate semaglutide or tirzepatide.
- Saxenda: FDA-approved for weight loss.
- Victoza: FDA-approved for Type 2 Diabetes.
- Dosage: Daily injection starting at 0.6 mg, titrating up to 3.0 mg (Saxenda) or 1.8 mg (Victoza).
5. Other Notable GLP-1 Combinations
- Trulicity (Dulaglutide): A weekly injection primarily for diabetes, known for its extremely easy-to-use "auto-injector" pen.
- Soliqua (Lixisenatide/Insulin Glargine): A combination therapy for those who need both GLP-1 benefits and long-acting insulin.
Pros and Cons of the GLP-1 Category
Positives
- Significant Weight Loss: Clinical trials show 15%–22% body weight reduction in many users.
- Cardiovascular Benefits: Many GLP-1s are proven to reduce the risk of heart attack and stroke.
- Metabolic Repair: Improves insulin sensitivity and reduces A1c levels.
- Versatility: Now available in both weekly injections and daily oral tablets.
Negatives
- Gastrointestinal Side Effects: Nausea, vomiting, and constipation are common during the titration phase.
- High Cost: Without insurance, retail prices often exceed $1,000 per month.
- Supply Issues: High demand has led to frequent national shortages of popular brands.
- Muscle Loss: Rapid weight loss can lead to loss of lean muscle mass if not paired with protein intake and resistance training.
Evaluation Criteria: How We Break Down GLP-1s
When looking at the glp 1 medication list, we analyze several key factors to help you decide which treatment path might be right for you.
- Efficacy (9/10): Most modern GLP-1s score exceptionally high in clinical weight loss results.
- Convenience (7/10): Weekly injections are convenient, but oral pills like Foundayo are pushing this score higher.
- Tolerability (6/10): The side effect profile remains the biggest barrier for many new users.
- Availability (5/10): Ongoing shortages continue to impact the accessibility of several top-tier brands.
Conclusion: Which GLP-1 is Right for You?
The "best" medication on the glp 1 drugs list depends entirely on your health history, your tolerance for needles, and your budget. If you want the highest weight loss percentage, Tirzepatide (Zepbound) currently leads the pack. If you want the convenience of a pill without dietary restrictions, Foundayo is the new gold standard.
Before making a decision, we recommend comparing the providers who facilitate these prescriptions. The onboarding process, cost of care, and medical support vary significantly between telehealth platforms.
See also:
- How to Get a GLP-1 Prescription Online
- Telehealth Provider Comparison Tool
- Calculating the True Monthly Cost of Semaglutide
Summary Data Block
- Total FDA-Approved Brands: 10+
- Latest Approval: Foundayo (April 2026)
- Primary Delivery: Injection (Weekly), Oral (Daily)
- Primary Target: Glucagon-like peptide-1 receptor
- Average Weight Loss: 10-22% of body weight (depending on medication)
Disclaimer: This guide is for informational purposes only and does not constitute medical advice. Always consult with a licensed healthcare professional before starting any new medication.
